Compile Data Set for Download or QSAR
Report error Found 80 Enz. Inhib. hit(s) with all data for entry = 13083
TargetPoly [ADP-ribose] polymerase 1(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM757047(US20250221987, Example 16-2)
Affinity DataIC50: 0.300nMAssay Description:1) 50 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM757062(US20250221987, Example 46-2)
Affinity DataIC50: 0.300nMAssay Description:1) 50 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM757044(N-methyl-5-[(1S,6R)-5-((6-oxo-5H,7H,8H,9H-cyclopen...)
Affinity DataIC50: 0.300nMAssay Description:1) 50 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM757050(N-methyl-5-((1S,6R)-5-((6-oxo-6,8,9,10-tetrahydro-...)
Affinity DataIC50: 0.300nMAssay Description:1) 50 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM757061(N-cyclopropyl-5-((1S,6R)-5-((7-ethyl-6-oxo-5,6-dih...)
Affinity DataIC50: 0.400nMAssay Description:1) 50 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM757032(US20250221987, Example 5)
Affinity DataIC50: 0.5nMAssay Description:1) 50 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM757056(US20250221987, Example 40-2)
Affinity DataIC50: 0.5nMAssay Description:1) 50 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM757045(US20250221987, Example 12-2)
Affinity DataIC50: 0.5nMAssay Description:1) 50 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM757034(US20250221987, Example 5-2)
Affinity DataIC50: 0.5nMAssay Description:1) 50 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM757038(US20250221987, Example 7)
Affinity DataIC50: 0.600nMAssay Description:1) 50 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM757028(US20250221987, Example 2-2)
Affinity DataIC50: 0.600nMAssay Description:1) 50 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM757057(US20250221987, Example 41-2)
Affinity DataIC50: 0.600nMAssay Description:1) 50 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM757048(US20250221987, Example 29-2)
Affinity DataIC50: 0.700nMAssay Description:1) 50 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM757046(16-2 | US20250221987, Example 16-1)
Affinity DataIC50: 0.700nMAssay Description:1) 50 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM595760(US11591331, Example 90 | US20250221987, Example 1-...)
Affinity DataIC50: 0.700nMAssay Description:1) 50 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM757040(5-((1S,6R)-(5-((7-ethyl-6-oxo-5,6-dihydro-pyrido[3...)
Affinity DataIC50: 0.800nMAssay Description:1) 50 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM757063(US20250221987, Example AZD5305)
Affinity DataIC50: 0.900nMAssay Description:1) 50 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM757027(US20250221987, Example 2)
Affinity DataIC50: 0.900nMAssay Description:1) 50 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM757033(5-((1S,6R)-5-((7-ethyl-6-oxo-5,6-dihydro-pyrido[3,...)
Affinity DataIC50: 0.900nMAssay Description:1) 50 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM595766(US11591331, Example 96 | US20250221987, Example 1-...)
Affinity DataIC50: 0.900nMAssay Description:1) 50 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was co...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM757041(US20250221987, Example 10-2)
Affinity DataIC50: 0.900nMAssay Description:1) 50 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM757039(US20250221987, Example 10)
Affinity DataIC50: 1nMAssay Description:1) 50 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM757030(US20250221987, Example 2-4)
Affinity DataIC50: 1nMAssay Description:1) 50 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM757060(US20250221987, Example 46)
Affinity DataIC50: 1nMAssay Description:1) 50 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM757024(US20250221987, Example 1)
Affinity DataIC50: 1.10nMAssay Description:1) 50 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM757054(US20250221987, Example 38-2)
Affinity DataIC50: 1.20nMAssay Description:1) 50 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM757049(US20250221987, Example 30-2)
Affinity DataIC50: 1.20nMAssay Description:1) 50 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM757029(5-((1R,6R)-5-((7-ethyl-6-carbonyl-5,6-dihydro-1,5-...)
Affinity DataIC50: 1.5nMAssay Description:1) 50 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM757037(US20250221987, Example 6-2)
Affinity DataIC50: 1.5nMAssay Description:1) 50 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM757043(US20250221987, Example 11-2)
Affinity DataIC50: 1.5nMAssay Description:1) 50 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM757053(US20250221987, Example 37-2)
Affinity DataIC50: 1.90nMAssay Description:1) 50 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM757052(US20250221987, Example 33-2)
Affinity DataIC50: 2.30nMAssay Description:1) 50 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM757055(US20250221987, Example 39-2)
Affinity DataIC50: 2.40nMAssay Description:1) 50 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM757035(US20250221987, Example 6)
Affinity DataIC50: 2.5nMAssay Description:1) 50 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM757059(US20250221987, Example 43-2)
Affinity DataIC50: 2.70nMAssay Description:1) 50 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM757042(5-((1S,6R)-5-((3-ethyl-2-oxo-1,2-dihydropyrido[2,3...)
Affinity DataIC50: 3.90nMAssay Description:1) 50 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM757036(6-2 | US20250221987, Example 6-1)
Affinity DataIC50: 4.10nMAssay Description:1) 50 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM757058(US20250221987, Example 42-2)
Affinity DataIC50: 4.30nMAssay Description:1) 50 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM757051(US20250221987, Example 33-1)
Affinity DataIC50: 6.60nMAssay Description:1) 50 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM595760(US11591331, Example 90 | US20250221987, Example 1-...)
Affinity DataIC50: 11.4nMAssay Description:1) 100 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM757031(5-((4aS,7aR)-4-((7-ethyl-6-oxo-5,6-dihydro-1,5-nap...)
Affinity DataIC50: 12nMAssay Description:1) 50 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM757027(US20250221987, Example 2)
Affinity DataIC50: 14nMAssay Description:1) 100 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was c...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM757024(US20250221987, Example 1)
Affinity DataIC50: 15.4nMAssay Description:1) 100 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was c...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM757063(US20250221987, Example AZD5305)
Affinity DataIC50: 16nMAssay Description:1) 100 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was c...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM757044(N-methyl-5-[(1S,6R)-5-((6-oxo-5H,7H,8H,9H-cyclopen...)
Affinity DataIC50: 18nMAssay Description:1) 100 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was c...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM757047(US20250221987, Example 16-2)
Affinity DataIC50: 19nMAssay Description:1) 100 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was c...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM595766(US11591331, Example 96 | US20250221987, Example 1-...)
Affinity DataIC50: 26.7nMAssay Description:1) 100 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was c...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM757061(N-cyclopropyl-5-((1S,6R)-5-((7-ethyl-6-oxo-5,6-dih...)
Affinity DataIC50: 29nMAssay Description:1) 100 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was c...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM757048(US20250221987, Example 29-2)
Affinity DataIC50: 30nMAssay Description:1) 100 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was c...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Acerand Therapeutics (Hong Kong)

US Patent
LigandPNGBDBM757054(US20250221987, Example 38-2)
Affinity DataIC50: 30nMAssay Description:1) 100 ng/mL of histone coating buffer was prepared with 1×PBS, and 25 μL of coating buffer was transferred to a 384-well reaction plate, which was c...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/26/2025
Entry Details
Go to US Patent

Displayed 1 to 50 (of 80 total ) | Next | Last >>
Jump to: